Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?

06.06.25 12:20 Uhr

Werte in diesem Artikel
Aktien

12,49 EUR 0,08 EUR 0,66%

Indizes

6.005,9 PKT 5,5 PKT 0,09%

The Invesco S&P Ultra Dividend Revenue ETF (RDIV) was launched on 10/01/2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Value segment of the US equity market.The fund is sponsored by Invesco. It has amassed assets over $771.16 million, making it one of the average sized ETFs attempting to match the Large Cap Value segment of the US equity market.Why Large Cap ValueCompanies that fall in the large cap category tend to have a market capitalization above $10 billion. Considered a more stable option, large cap companies boast more predictable cash flows and are less volatile than their mid and small cap counterparts.Value stocks are known for their lower than average price-to-earnings and price-to-book ratios, but investors should also note their lower than average sales and earnings growth rates. While value stocks have outperformed growth stocks in nearly all markets when you consider long-term performance, growth stocks are more likely to outpace value stocks in strong bull markets.CostsExpense ratios are an important factor in the return of an ETF and in the long term, cheaper funds can significantly outperform their more expensive counterparts, other things remaining the same.Annual operating expenses for this ETF are 0.39%, putting it on par with most peer products in the space.It has a 12-month trailing dividend yield of 4.19%.Sector Exposure and Top HoldingsETFs offer a diversified exposure and thus minimize single stock risk but it is still important to delve into a fund's holdings before investing. Most ETFs are very transparent products and many disclose their holdings on a daily basis.This ETF has heaviest allocation to the Financials sector--about 25.40% of the portfolio. Energy and Healthcare round out the top three.Looking at individual holdings, Best Buy Co Inc (BBY) accounts for about 5.19% of total assets, followed by Us Bancorp (USB) and Bristol-Myers Squibb Co (BMY).The top 10 holdings account for about 47.92% of total assets under management.Performance and RiskRDIV seeks to match the performance of the OFI Revenue Weighted Ultra Dividend Index before fees and expenses. The S&P 900 Dividend Revenue-Weighted Index is constructed using a rules-based methodology that starts with the S&P 900 Index, subject to a maximum 5% per company weighting.The ETF has lost about -1.75% so far this year and is up about 7.04% in the last one year (as of 06/06/2025). In the past 52-week period, it has traded between $42.44 and $52.79.The ETF has a beta of 0.92 and standard deviation of 19% for the trailing three-year period, making it a medium risk choice in the space. With about 62 holdings, it effectively diversifies company-specific risk.AlternativesInvesco S&P Ultra Dividend Revenue ETF holds a Zacks ETF Rank of 2 (Buy), which is based on expected asset class return, expense ratio, and momentum, among other factors. Because of this, RDIV is a great option for investors seeking exposure to the Style Box - Large Cap Value segment of the market. There are other additional ETFs in the space that investors could consider as well.The Schwab U.S. Dividend Equity ETF (SCHD) and the Vanguard Value ETF (VTV) track a similar index. While Schwab U.S. Dividend Equity ETF has $68.29 billion in assets, Vanguard Value ETF has $133.45 billion. SCHD has an expense ratio of 0.06% and VTV charges 0.04%.Bottom-LineWhile an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional and retail investors due to their low costs, transparency, flexibility, and tax efficiency.To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.Want key ETF info delivered straight to your inbox?Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.Get it free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Invesco S&P Ultra Dividend Revenue ETF (RDIV): ETF Research Reports Bristol Myers Squibb Company (BMY): Free Stock Analysis Report Best Buy Co., Inc. (BBY): Free Stock Analysis Report U.S. Bancorp (USB): Free Stock Analysis Report Vanguard Value ETF (VTV): ETF Research Reports Schwab U.S. Dividend Equity ETF (SCHD): ETF Research ReportsThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf :be

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf :be

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Invesco Ltd

Wer­bung

Analysen zu Invesco Ltd

DatumRatingAnalyst
31.01.2019Invesco Equal WeightBarclays Capital
11.01.2019Invesco HoldDeutsche Bank AG
13.02.2018Invesco BuyDeutsche Bank AG
08.09.2017Invesco OverweightBarclays Capital
30.06.2017Invesco OutperformRBC Capital Markets
DatumRatingAnalyst
13.02.2018Invesco BuyDeutsche Bank AG
08.09.2017Invesco OverweightBarclays Capital
30.06.2017Invesco OutperformRBC Capital Markets
08.01.2016Invesco BuyDeutsche Bank AG
02.11.2012Invesco outperformRBC Capital Markets
DatumRatingAnalyst
31.01.2019Invesco Equal WeightBarclays Capital
11.01.2019Invesco HoldDeutsche Bank AG
14.10.2016Invesco HoldDeutsche Bank AG
02.06.2016Invesco NeutralUBS AG
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Invesco Ltd nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen